首页> 外文期刊>The Journal of Infectious Diseases >Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae.
【24h】

Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae.

机译:溶血性嗜血杆菌(Haemophilus haemolyticus):一种人类呼吸道,可与流感嗜血杆菌区分开。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Haemophilus influenzae is a common pathogen in adults with chronic obstructive pulmonary disease (COPD). In a prospective study, selected isolates of apparent H. influenzae had an altered phenotype. We tested the hypothesis that these variant strains were genetically different from typical H. influenzae. METHODS: A prospective study of adults with COPD was conducted. Strains of apparent H. influenzae obtained from a range of clinical sources were evaluated by ribosomal DNA sequence analysis, multilocus sequence analysis, DNA-DNA hybridization, and sequencing of the conserved P6 gene. RESULTS: Variant strains were determined to be Haemophilus haemolyticus by means of 4 independent methods. Analysis of 490 apparent H. influenzae strains, identified by standard methods, revealed that 39.5% of sputum isolates and 27.3% of nasopharyngeal isolates were H. haemolyticus. Isolates obtained from normally sterile sites were all H. influenzae. In a prospective study, acquisitions of new strains of H. haemolyticus were not associated with exacerbations of COPD, whereas 45% of acquisitions of new strains of H. influenzae were associated with exacerbations. CONCLUSIONS: Standard methods do not reliably distinguish H. haemolyticus from H. influenzae. H. haemolyticus is a respiratory tract commensal. The recognition that some strains of apparent H. influenzae are H. haemolyticus substantially strengthens the association of true H. influenzae with clinical infection.
机译:背景:流感嗜血杆菌是成人慢性阻塞性肺疾病(COPD)的常见病原体。在一项前瞻性研究中,选定的明显的流感嗜血杆菌分离株具有改变的表型。我们检验了这些变异株与典型的流感嗜血杆菌在遗传上不同的假设。方法:对成年人COPD进行了前瞻性研究。通过核糖体DNA序列分析,多位点序列分析,DNA-DNA杂交和保守的P6基因测序,评估了从一系列临床来源获得的明显的流感嗜血杆菌菌株。结果:通过4种独立的方法确定了变异株为溶血性嗜血杆菌。通过标准方法对490例明显的流感嗜血杆菌菌株的分析表明,39.5%的痰分离株和27.3%的鼻咽分离株是溶血性杆菌。从正常无菌场所获得的分离株均为流感嗜血杆菌。在一项前瞻性研究中,获得新的溶血嗜血杆菌菌株与COPD恶化无关,而获得新流感嗜血杆菌菌株45%则与恶化有关。结论:标准方法不能可靠地区分溶血性嗜血杆菌和流感嗜血杆菌。溶血性嗜血杆菌是呼吸道常见症状。某些明显的流感嗜血杆菌菌株是溶血性嗜血杆菌的认识大大加强了真正的流感嗜血杆菌与临床感染的联系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号